Literature DB >> 4077887

Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules.

G E Visscher, R L Robison, H V Maulding, J W Fong, J E Pearson, G J Argentieri.   

Abstract

The biodegradation of the copolymer 50:50 poly(DL-lactide-co-glycolide)-lypressin microcapsules was studied by light and electron microscopic methods and 14C release. Intramuscular injection sites of microcapsules in rats were studied by dissecting and conventional light microscopy as well as scanning (SEM) and transmission electron microscopy. A minimal localized acute myositis was seen initially at the injection sites. By Day 4, a few small foreign body giant cells were present participating in the minimal foreign body response. Later the inflammatory cells decreased and the individual microcapsules were walled off by immature fibrous connective tissue and large syncytial foreign body giant cells. By Day 35, definitive changes in some microcapsules, consisting of a granular and slightly eroded appearance of the internal matrix, were seen by SEM. By Day 42, the outer rims of the microcapsules were extensively eroded. At Day 56, the inflammatory and connective tissue reactions were almost completely resolved and biodegradation continued so that only remnant pieces of the microcapsules were present at Day 63. The morphologic picture correlated well with loss of 14C radioactivity, which could no longer be detected at the injection sites on Day 56. Phagocytosis did not seem to be an important factor in the biodegradation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077887     DOI: 10.1002/jbm.820190315

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  30 in total

1.  Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.

Authors:  D C Quenelle; G A Winchester; J K Staas; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice.

Authors:  D C Quenelle; J K Staas; G A Winchester; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 3.  Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors:  Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

4.  Towards more realistic in vitro release measurement techniques for biodegradable microparticles.

Authors:  D Klose; N Azaroual; F Siepmann; G Vermeersch; J Siepmann
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

5.  Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads.

Authors:  D P Nicolau; L Nie; P R Tessier; H P Kourea; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

6.  Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.

Authors:  Samuel K Lai; Jung Soo Suk; Amanda Pace; Ying-Ying Wang; Ming Yang; Olcay Mert; Jeane Chen; Jean Kim; Justin Hanes
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

7.  Inhibition of angiogenesis- and inflammation-inducing factors in human colon cancer cells in vitro and in ovo by free and nanoparticle-encapsulated redox dye, DCPIP.

Authors:  Fadee G Mondalek; Sivapriya Ponnurangam; Janita Govind; Courtney Houchen; Shrikant Anant; Panayotis Pantazis; Rama P Ramanujam
Journal:  J Nanobiotechnology       Date:  2010-07-15       Impact factor: 10.435

8.  Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.

Authors:  Ze Lu; Max Tsai; Dan Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Pharmacol Exp Ther       Date:  2008-09-09       Impact factor: 4.030

9.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

10.  Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain.

Authors:  Erin D Milligan; Ryan G Soderquist; Stephanie M Malone; John H Mahoney; Travis S Hughes; Stephen J Langer; Evan M Sloane; Steven F Maier; Leslie A Leinwand; Linda R Watkins; Melissa J Mahoney
Journal:  Neuron Glia Biol       Date:  2006-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.